PDCD1 and neoplasm: In conclusion, the anti-tumor effects induced by anti-PD-1 antibody treatment were found to be attenuated in STZ-induced diabetic mice, which was accompanied by decreased infiltration of CD11c+ cells and CD8+ T cells and decreased expression of CCL7 and CXCL9.